Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc.

Overview
Date Founded

1975

Headquarters

1000 ALFRED NOBEL DRIVE, HERCULES, CA, 94547

Type of Company

Public

Employees (Worldwide)

8,260

Industries

Industrial Machinery & Manufacturing
Medical Products & Equipment
IT Consulting & Services
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Contact Data
Trying to get in touch with decision makers at Bio-Rad Laboratories Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman of the Board, President & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Executive Vice President & Chief Operating Officer

Executive Vice President, General Counsel & Secretary

Vice President, Corporate Controller & Principal Accounting Officer

Executive Vice President & Chief Strategy Officer

Vice President & Treasurer

Executive Vice President, President, Clinical Diagnostics Group

Executive Vice President, Global Commercial Operations

Executive Vice President, President, Life Science Group

Board of Directors

Former Chairman of the Board, President & Chief Executive Officer at Bio-Rad Laboratories Inc.

Co-Founder at Bio-Rad Laboratories Inc.

Director at Intermec, Inc.

Corporate Vice President, General Counsel at Edwards Lifesciences Corp.

Former Executive Vice President, Finance & Business Development & Chief Financial Officer at Allergan, Inc.

Deloitte & Touche LLP

Chief Executive Officer & Owner at Jackryn France, Inc.

Paths to Bio-Rad Laboratories Inc.
Potential Connections via
Relationship Science
You
Bio-Rad Laboratories Inc.
Owners & Shareholders
Details Hidden

Levin Easterly Partners employs fundamental, bottom-up value investment strategies which aim to preserve capital and generate profit consistently. The firm believes that the fundamental approach to select attractive long equity positions is the key to achieving sustained and substantial appreciation. Levin Easterly Partners invests client assets primarily in large-cap, mid-cap and all-cap equity securities of both domestic and foreign issuers traded on a US exchange. The firm primarily offers four long-only value biased investment strategies that focus on US traded securities: (1) Large-Cap, (2) Mid-Cap, (3) All-Cap, and (4) Financial Sector - primarily focused on large-cap and mid-cap equities.

Details Hidden

Atlanta Capital offers investment advisory services in a variety of equity, fixed income and mixed-asset strategies. In-depth fundamental analysis is the primary basis for their investment decision making process. Atlanta Capital invests principally in traditional equity (common stocks and equivalents) and debt securities. The firm seeks to achieve above-average long-term risk adjusted returns through emphasis on high quality equity or debt instruments they believe have unrecognized value or investment potential. For equities, high quality is generally measured by a company's demonstrated history of consistent growth and stability in earnings. For debt instruments, high quality typically relates to the probability of repayment (credit risk) and the predictability of when principal repayment will occur (stability of cash flow). Atlanta Capital operates with three distinct investment teams, Growth Equity, Core Equity and Fixed Income, each leveraging a central investment philosophy.

Details Hidden

Point72 Asset Management is a research-driven investment management firm built around a core position in discretionary long/short equities, as well as systematic, global macro and other strategies. The firm seeks to achieve each Point72 Fund's investment objective by focusing primarily on long/short equity and systematic investment strategies and seeks to employ other investment strategies opportunistically. Point72 Asset Management employs these strategies in attempting to achieve an attractive return on capital consistent with principles that are designed to reduce the risk of permanent capital loss. The firm is an active investor and will use significant leverage, engages in short-sale transactions, and exercises various options and arbitrage strategies. In implementing specific strategies, Point72 Asset Management may manage assets such as equities (including listed, unlisted, traded or privately offered, domestic, foreign, depository receipts and preferred); secured and unsecured debt (including both corporate and sovereign, mortgage-backed to-be-announced securities, bank loans, loans originated by a Point72 Fund, vendor claims and other legal and/or contractual claims); futures; forward contracts; options; convertible bonds and preferred stock; derivative instruments, including listed and over-the-counter, swaps and other equity or fixed income related instruments; contracts for differences; currencies; and commodities.

Recent Transactions
Details Hidden

Bio-Rad Laboratories Inc. purchases Bridger Technologies, Inc.

Details Hidden

Bio-Rad Laboratories Inc. purchases RainDance Technologies, Inc. from Alloy Ventures, Inc., Quaker Partners Management LP, Acadia Woods Partners LLC, Northgate Capital LP, Cambridge Enterprise Ltd., Mohr Davidow Ventures, GE Ventures LLC, LR Management Co. LLC

Details Hidden

Bio-Rad Laboratories Inc. purchases GnuBIO, Inc.

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Accountant

Advised onBio-Rad Laboratories Inc. purchases Pasteur Sanofi Diagnostics from Sanofi-Synthélabo SA

Legal Advisor

Advised onBio-Rad Laboratories Inc. purchases RainDance Technologies, Inc. from Alloy Ventures, Inc., Quaker Partners Management LP, Acadia Woods Partners LLC, Northgate Capital LP, Cambridge Enterprise Ltd., Mohr Davidow Ventures, GE Ventures LLC, LR Management Co. LLC

Accountant

Advised onBio-Rad Laboratories Inc. purchases Verdot Industrie from Groupe BioAccess

Legal Advisor

Advised onBio-Rad Laboratories Inc. purchases RainDance Technologies, Inc. from Alloy Ventures, Inc., Quaker Partners Management LP, Acadia Woods Partners LLC, Northgate Capital LP, Cambridge Enterprise Ltd., Mohr Davidow Ventures, GE Ventures LLC, LR Management Co. LLC

Associate

Advised onBio-Rad Laboratories Inc. purchases RainDance Technologies, Inc. from Alloy Ventures, Inc., Quaker Partners Management LP, Acadia Woods Partners LLC, Northgate Capital LP, Cambridge Enterprise Ltd., Mohr Davidow Ventures, GE Ventures LLC, LR Management Co. LLC

Legal Advisor

Advised onBio-Rad Laboratories Inc. purchases RainDance Technologies, Inc. from Alloy Ventures, Inc., Quaker Partners Management LP, Acadia Woods Partners LLC, Northgate Capital LP, Cambridge Enterprise Ltd., Mohr Davidow Ventures, GE Ventures LLC, LR Management Co. LLC

Advisors & Consultants
Advisor

Former Chief Financial Officer, Executive Vice President & Head, Investor Relations at Bio-Rad Laboratories Inc.

Legal Advisor

General Counsel & Advisor at Pixim, Inc.

Legal Advisor

Partner at Jones Day

Clients

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Medford, NY.

DCC Plc provides international sales, marketing, and business support services. It operates through the following segments: DCC LPG, DCC Retail & Oil, DCC Healthcare, and DCC Technology. The DCC LPG segment operates a liquefied petroleum gas (LPG) sales and marketing business with operations in Europe, Asia, and the US with a developing business in the retailing of natural gas and electricity. The DCC Retail & Oil segment is involved in the sales, marketing, and retailing of transport and commercial fuels, heating oils, and related products and services in Europe. The DCC Healthcare segment provides products and services to healthcare providers and health and beauty brand owners. The DCC Technology segment serves as a route-to-market and supply chain partner for global technology brands. The company was founded by Jim Flavin in 1976 and is headquartered in Dublin, Ireland.

Key Stats and Financials As of 2018
Market Capitalization
$9.87B
Total Enterprise Value
$6.61B
Earnings Per Share
$12.1
Revenue
$2.29B
Debt TEV
0.07x
Total Debt
$439M
Enterprise Value Sales
2.89x
TEVNet Income
18.08x
Net Profit
$366M
Total Equity
$4.02B
EBITDAMargin
14.02%
Enterprise Value EBITDAOperating
20.6x
EBITDA
$321M
Three Year Compounded Annual Growth Rate Of Revenue
4.27%
Five Year Compounded Annual Growth Rate Of Revenue
1.43%
Non-Profit Donations & Grants
$10K - $30K
2013
$1,000 +
2013
$10K - $30K
2012
Investments
Details Hidden

Osler Diagnostics Ltd. engages in research and development in biotechnology. The company was founded by Jason Davis and Paulo R. Bueno and is headquartered in Oxford, the United Kingdom.

Details Hidden

Mederi Therapeutics, Inc. designs, manufactures and markets products for the treatment of diseases and conditions that affect the human gastrointestinal tract. It offers mederi technology, stretta therapy, and secca therapy products. The company was founded by Steven P. Novak in 2008 and is headquartered in Norwalk, CT.

Investors
Details Hidden

Investor at Neuronetics, Inc.

Suppliers
Luminex Corp. Medical Support Services | Austin, TX

Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX.

Quotient Ltd. Pharmaceuticals | Eysins, VD

Quotient Ltd. is a commercial-stage diagnostics company. It provides immunohematology products to hospitals and blood banks. The company develops, manufactures and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. Quotient was founded on January 28, 2012 and is headquartered in Eysins, Switzerland.

Marketo, Inc. Market & Policy Research | San Mateo, California

Marketo, Inc. engages in the provision of digital marketing platform. Its products include marketing automation, account-based marketing, email, mobile, social, digital ads, web, marketing analytics, content, and market sales engage. It also offers lead management, email marketing, consumer marketing, customer base marketing, and mobile marketing solutions. The company was founded by Phillip M. Fernandez, Jonathan Miller, and David Morandi on January 20, 2006 and is headquartered in San Mateo, CA.

Competitors
Danaher Corporation Industrial Machinery & Manufacturing - Washington, DC

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following five segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products and services that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as to improve the aesthetics of the human smile. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.

General Electric Company Power & Utilities - Boston, MA

General Electric Co. is a technology and financial services company that develops and manufactures products for the generation, transmission, distribution, control and utilization of electricity. Its products and services include aircraft engines, power generation, water processing, security technology, medical imaging, business and consumer financing, media content and industrial products. The company operates through the following segments: Power, Oil & Gas, Aviation, Healthcare, Transportation, Appliances & Lighting and GE Capital. The Power segment serves power generation, industrial, government and other customers worldwide with products and services related to energy production. The Oil & Gas segment supplies mission critical equipment for the global oil and gas industry, used in applications spanning the entire value chain from drilling and completion through production, liquefied natural gas and pipeline compression, pipeline inspection, and downstream processing in refineries and petrochemical plants. The Aviation segment products and services include jet engines, aerospace systems and equipment, replacement parts and repair and maintenance services for all categories of commercial aircraft; for a wide variety of military aircraft, including fighters, bombers, tankers and helicopters; for marine applications; and for executive and regional aircraft. The Healthcare segment products include diagnostic imaging systems such as magnetic resonance, computed tomography and positron emission Tomography scanners, X-ray, nuclear imaging, digital mammography and molecular imaging technologies. The Transportation segment engages in global technology and supplier to the railroad, mining, marine and drilling industries. The Appliances & Lighting segment products include major appliances and related services for products such as refrigerators, freezers, electric and gas ranges, cooktops, dishwashers, clothes washers and dryers, microwave ovens, room air conditioners, residential water systems for filtration, softening and heating, and hybrid water heaters. The GE Capital segment offers financial services and products worldwide for businesses of all sizes, services include commercial loans and leases, fleet management, financial programs, credit cards, personal loans and other financial services. The company was founded by Thomas A. Edison in 1878 and is headquartered in Boston, MA.

Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Awards & Honors
Rank #965
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Bio-Rad Laboratories Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Bio-Rad Laboratories Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Bio-Rad Laboratories Inc..